CLS is largest statewide advocacy and business leadership trade association representing the life sciences industry. CLSAsupports over 1,300 corporate member organization focused on the growth of Cali ...

Canary Cure Therapeutics is a late-stage preclinical biotechnology company pioneering a paradigm shift in the treatment of obesity and metabolic diseases. While first-generation therapies have validat ...

A clinical stage biotech company advancing cell therapy platform with first asset at phase III for treating osteoarthritis

Chipscreen is a public biotech in China dedicated for FIC/BIC innovative drug development (688321.SH) in the areas of Oncology, Metabolic and Autoimmune disease. For the moment, we have two FIC produc ...

Chubb is the world’s largest publicly traded property and casualty insurer.

Citius is a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products with a focus on oncology and anti-infectives in adjunct cancer care.

Consano Bio is a clinical-stage biotechnology company dedicated to transforming the treatment of painful and debilitating orthopedic conditions through a new class of disease-modifying therapeutics th ...

Corner is pioneering a new class of immunotherapies. Our versatile dendritic cell hyperactivation (hDC) platform is unique in its ability to address a virtually unbounded range of cancers and infectio ...